baber/WOPTO huggingface dataset:
Patent CA-3047919-A1 (CA)
Inventor: HERZIG YOAV
IPC: B64D1/04
Filed: 2017-12-27
Abstract: An aircraft pylon is provided, configured for mounting to the underside of an aircraft wing projecting from a fuselage and for carrying an external payload suspended therefrom. The pylon comprises an attachment mechanism configured for facilitating mounting of the pylon to the aircraft wing, and a carrying arrangement configured for carrying the payload and being pivotally articulated to the attachment mechanism. The pylon is configured to selectively pivot the carrying arrangement about a pylon axis between a vertical position in which it is suspended in a substantially vertical orientation, and a tilted position in which it is tilted toward the fuselage.
Patent CA-3049177-A1 (CA)
Inventor: WRAITH DAVID
IPC: A61K38/17
Filed: 2018-01-04
Abstract: The present invention relates to a therapeutic method using a tolerogenic peptide. In particular, the invention relates to a dosage regimen fora tolerogenic peptide. The therapeutic method can be used to treat or prevent conditions associated with aberrant, hypersensitivityor pathological immune responses to endogenous or exogenous proteins that results in a loss of immune tolerance.
Patent CA-3055215-A1 (CA)
Title: Amines polycycliques utilisees comme modulateurs des recepteurs opioides
Inventor: WANG XIAODONG
IPC: A61K31/4025
Filed: 2018-03-12
Abstract: La présente invention concerne un genre d'amines polycycliques qui sont utiles en tant que modulateurs des récepteurs opioïdes. Les composés de l'invention sont utiles dans des méthodes thérapeutiques et diagnostiques, y compris pour le traitement de la douleur, de troubles neurologiques, de troubles cardiaques, de troubles intestinaux, la dépendance aux drogues et à l'alcool, l'overdose de médicament, les troubles urinaires, les troubles respiratoires, la dysfonction sexuelle, le psoriasis, le rejet de greffe ou le cancer.
Patent CA-3056822-A1 (CA)
Title: Infusion assembly, containment vessel provided with such an infusion assembly, kit for assembling the same, and corresponding methods of manufacturing, operating and use associated thereto
Inventor: MALONI HALYSHA KAUR
IPC: A47G19/14
Filed: 2018-03-19
Abstract: A containment vessel (1) with integrated infusion capability for infusing a solid substance with a liquid. The containment vessel (1) includes a main containment body (3), a dispensing assembly (5), an infusion assembly (9), a transmission assembly (15), and an actuating assembly (17), the actuating assembly (17) being operatively connectable to the transmission assembly (15) for displacing one of inner and outer infusion components (11,13) with respect to the other via the transmission assembly (15), so as to in turn selectively operate the infusion assembly (9) between active and inactive modes, the actuating assembly (17) being manually operated and having at least one actuating component (17a), such an actuating ring (27), for example, being provided about a peripheral surface of the containment vessel (1).
Patent CA-3061624-A1 (CA)
Inventor: CULLY EDWARD H
IPC: A61B17/34
Filed: 2018-06-19
Abstract: An endoluminal access device including an outer sheath defining a lumen and a guide assembly. The guide assembly includes an expandable portion configured to be transitioned between a collapsed configuration having a first diameter and an expanded configuration having a second diameter that is greater than the first diameter. The expandable portion includes a first arm defining a first lumen and an aperture in communication with the first lumen. The expandable portion is configured to expand outwardly from a central longitudinal axis when the expandable portion transitions to the expanded configuration and to deflect inwardly toward the central longitudinal axis when the expandable portion is transitioned to the collapsed configuration. The endoluminal access device further includes an endoluminal tool deliverable from the first lumen of the first arm and outwardly from the aperture of the first arm.
Patent CA-3062377-A1 (CA)
Title: Pbch transmission method and apparatus
Inventor: LIU JIANQIN
IPC: H04B7/26
Filed: 2018-05-04
Abstract: This application provides a PBCH transmission method and an apparatus. The method includes: receiving, by a terminal device, a PBCH sent by a network device, where the PBCH includes seven most significant bits of an SFN of a radio frame in which the PBCH is located; determining, by the terminal device, a least significant bit of the PBCH based on indication information of the least significant bit of the SFN; determining, by the terminal device based on the PBCH, at least one of a scrambling code, a CRC check mask, or a redundancy version of the PBCH, and determining two remaining bits of the SFN based on a one-to-one correspondence between the two remaining bits of the SFN and the at least one of the scrambling code, the CRC check mask, or the redundancy version of the PBCH; and determining, by the terminal device based on the least significant bit, the seven most significant bits, the second least significant bit, and the third least significant bit of the SFN, the SFN of the radio frame in which the PBCH is located. This reduces complexity of blind detection. In addition, the method can be applicable to scenarios with different quantities of PBCHs sent within one PBCH TTI. An application scope is relatively wide.
Patent CA-3062479-A1 (CA)
Title: Bispecific recombinant protein and use thereof
Inventor: SONG LIPING
IPC: A61K39/395
Filed: 2018-05-08
Abstract: Provided is a bispecific recombinant protein, comprising a high affinity tumor-targeting arm and a low affinity fusion protein blocking the interaction of CD47 with SIRP.alpha.. The antibody corresponding to the high affinity tumor-targeting arm does not bind to CD47, and its binding affinity to the target antigen on the tumor cell is at least 6 times as great as the binding affinity of monomer fusion protein homodimer, corresponding to the low affinity fusion protein blocking the interaction of CD47 with SIRP.alpha., to a CD47 on the tumor cell, wherein the low affinity fusion protein blocking the interaction of CD47 with SIRP.alpha. comprises a SIRP.alpha. extracellular truncation. Also provided are nucleic acid molecules encoding recombinant proteins and the use of the recombinant proteins and nucleic acid molecules in the manufacture of a medicament for treating tumors.
Patent CA-3063208-A1 (CA)
Inventor: LINDAL AKE
IPC: A61K47/06
Filed: 2018-05-22
Abstract: L'invention concerne une formulation formant une mousse et une méthode d'administration d'un composé médicalement actif ou cosmétique ou analgésique à la peau, à une plaie ou à une cavité corporelle. La formulation formant une mousse contient des cristaux de monoglycéride, un agent gonflant hydrophile en une quantité permettant de faire gonfler la composition formant une mousse et former une mousse, de l'eau, et un composé médical, cosmétique ou analgésique. La composition formant une mousse est d'une application convenant à la peau, aux plaies, et aux cavités corporelles lorsqu'elle est gonflée pour former la mousse, et la mousse fond à une température corporelle pour libérer le contenu. L'invention concerne également une composition formant une mousse servant comme véhicule pour administrer un agent actif.
Patent CA-3065472-A1 (CA)
Title: Downhole method and apparatus
Inventor: BRUCE STEPHEN EDMUND
IPC: E21B33/129
Filed: 2011-11-16
Abstract: A downhole apparatus is provided which includes a base pipe, a plurality of axially extending pressure deformable members mounted around the base pipe and at least one circumferential retaining ring located externally of the members. Further, a downhole method includes locating a plurality deformable members on a base pipe in a deflated configuration, locating at least one retaining ring over the deflated deformable members to thereby retain the deformable members radially, and inflating the deformable members to extend radially beyond the at least one retaining ring to thereby retain the at least one ring axially along the deformable members.
Patent CA-3065487-A1 (CA)
Title: Analog audio patchbay under digital control
Inventor: NAKONCHENY DARREN
IPC: H04Q1/56
Filed: 2019-12-18
Abstract: The present invention provides for an analog audio patchbay comprising a first plurality of connectors capable of receiving a plurality analog electronic signals, a second plurality of connectors capable of transmitting a plurality of analog electronic signals, and a circuit board extending from the first plurality to the second plurality
Patent CA-3067125-A1 (CA)
Title: A sample cartridge for incubating and/or analyzing a dispersion of particles, cells or droplets
Inventor: SCHULZ TORSTEN
IPC: B01F11/00
Filed: 2018-07-02
Abstract: The present invention relates to a sample cartridge for incubating and/or analyzing a dispersion of particles, cells or droplets and/or for performing biochemical reactions with or in such dispersion. The present invention furthermore relates to a device for incubating a dispersion of particles, cells or droplets and/or for performing a biochemical reaction therewith. Moreover, the present invention also relates to the use of a sample cartridge or of a device for generating and/or processing a dispersion of particles, cells or droplets. Moreover, the present invention relates to a method of processing a dispersion of particles, cells or droplets. Furthermore, the present invention relates to a method of generating a dispersion of droplets and to a method of generating a dispersion of solid or semi-solid particles.
Patent CA-3067283-A1 (CA)
Title: Method and electronic device for determining the temperature of a metal strip, related control method, computer program, control apparatus and hot rolling installation
Inventor: JACOLOT RONAN
IPC: B21B37/76
Filed: 2017-06-26
Abstract: This method for determining the temperature of a metal strip inside a cooling apparatus of a hot rolling installation is implemented by an electronic device. This method includes acquiring a temperature measure of a strip portion at a current time instant; estimating, at the current time instant, a heat flux extracted from the strip portion inside the cooling apparatus according to a thermal model, and computing a strip portion temperature at a next time instant from the acquired temperature measure and the estimated extracted heat flux. The thermal model models an air cooling of the strip portion, a coolant header cooling of the strip portion by a coolant header and a remaining coolant cooling of the strip portion, wherein for the coolant header cooling the model models both an impingement cooling of the strip portion and a parallel flow cooling of the strip portion.
Patent CA-3069486-A1 (CA)
Title: A poultry euthanizing system
Inventor: BRUBAKER CHAD
IPC: A22B3/08
Filed: 2020-01-23
Abstract: Disclosed herein is a system including a portable device for euthanizing sick or infirm poultry. The device includes a chamber with a lid and a canister of compressed carbon dioxide that communicates with the interior of the chamber, and controls that include opening and closing the chamber's lid with a pneumatic cylinder, driven by the same source of compressed carbon dioxide used to euthanize the poultry. A sick or infirm bird in place in the chamber and with the chamber on its shelf on the frame of the present system and the start button on the controls is pressed. The lid is automatically closed by pressing the start button, whereupon the interior of the chamber fills with carbon dioxide and a timer is started so that, after approximately one minute, the lid opens so the dead bird may be removed from the flock.
Patent CA-3072129-A1 (CA)
Title: Method for purifying proteins
Inventor: SUTTER HARRY-JAMES
IPC: C07K1/22
Filed: 2018-08-29
Abstract: The present invention relates to a method for purifying proteins, such as Fc fusion proteins or antibodies, from a sample comprising said proteins and impurities, through the use of a three-chromatographic columns procedure, including a chromatography on hydroxyapatite- and/or Fluorapatite-containing material. The invention is also concerned with pharmaceutical compositions comprising the purified proteins obtainable by the process of the invention.
Patent CA-3074595-A1 (CA)
Title: Compositions topiques
Inventor: QUAY STEVEN C
IPC: A61K31/138
Filed: 2018-09-10
Abstract: La présente invention concerne une nouvelle composition topique comprenant au moins un agent actif et un procédé de fabrication de cette composition. Certains composés ont été combinés pour produire une composition stable comprenant au moins un agent actif tel que des modulateurs sélectifs du récepteur des oestrogènes et des inhibiteurs d'aromatase. La présente invention concerne également des méthodes de traitement de troubles hormono-dépendants du sein et de troubles hormono-dépendants du tractus reproducteur.
Patent CA-3075930-A1 (CA)
Title: System and method for detecting decoupling of an auscultatory sound sensor from a test-subject
Inventor: LABONTE DANIEL
IPC: A61B7/04
Filed: 2018-09-19
Abstract: At least one of at least one data-dependent scale factor (SF) or at least one data-dependent detection threshold (DTi) is determined responsive to at least one block of time-series data (S) of an auscultatory-sound signal (16, 16.1, 16.1', 16.1'') generated by an auscultatory-sound sensor (12) operatively coupled to a portion of the skin (38) of a test-subject (22), wherein the at least one data-dependent scale factor (SF) or at least one data-dependent detection threshold (DTi) provides a measure of a range of values of the at least one block of time-series data (S) in relation to a predetermined metric (SFMAX, DT, DTMIN), and is used to determine whether or not the auscultatory-sound sensor (12) is either debonded or detached from the skin (38) of the test-subject (22).
Patent CA-3076923-A1 (CA)
Title: Rql phase-mode flip-flop
Inventor: BRAUN ALEXANDER LOUIS
IPC: H03K3/38
Filed: 2018-10-17
Abstract: A reciprocal quantum logic (RQL) phase-mode flip-flop includes a storage loop and a comparator, each of which includes Josephson junctions (JJs). A data input, provided as a positive or negative single flux quantum (SFQ) pulse, is stored in the storage loop to set the storage loop in a positive or negative state, respectively, effectively biasing an output JJ shared between the storage loop and a comparator. The data input is captured to the output upon the receipt of a logical clock SFQ reciprocal pulse pair to the comparator, when one of the pulses in the pair causes the output JJ to preferentially trigger over an escape junction in the comparator, owing to the output JJ having been biased by current in the storage loop.
Patent CA-3077319-A1 (CA)
Inventor: RAATIKAINEN JUHA
IPC: E05B15/00
Filed: 2018-11-01
Abstract: L'invention concerne un verrou de porte qui comprend un corps de verrou (2), un boulon (3), un fouillot (4), un poussoir (5A, 5B) de chaque côté du fouillot, et une solution de verrouillage (6) pour relier au moins l'un des poussoirs (5A, 5B) en liaison de transmission de force et hors liaison de transmission de force avec le fouillot (4). Le verrou de porte (1) comprend en outre une plaque déflectrice (7, 7A) entre le fouillot (4) et le poussoir (5A, 5B) au moins d'un côté du fouillot. La plaque déflectrice (7, 7A) comprend au moins une surface de support (8A, 8B, 8C), qui s'appuie contre le corps de verrou (2) ou contre une partie qui est reliée au corps de verrou d'une manière fixe. La plaque déflectrice ne peut donc pas tourner par rapport au corps de verrou (2). Une plaque déflectrice qui ne peut pas tourner empêche la transmission de la force de rotation du poussoir au fouillot.
Patent CA-3077994-A1 (CA)
Inventor: SHADFORTH IAN
IPC: A61M5/172
Filed: 2010-06-29
Abstract: Des méthodes et un dispositif de mesure et de gestion dun analyte sont fournis pour aviser un utilisateur atteint de diabète de la présence de certaines conditions liées à la glycémie. La méthode implique la mesure du taux de glucose avant un repas au moyen dun dispositif de mesure et de gestion dun analyte. La mesure du glucose avant le repas est indiquée dans la mémoire du dispositif de mesure et de gestion dun analyte à titre de taux de glycémie avant le repas. La mesure du glucose est effectuée après un repas au moyen dun dispositif de mesure et de gestion dun analyte. La mesure du glucose après le repas est indiquée dans la mémoire du dispositif de mesure et de gestion dun analyte à titre de taux de glycémie après le repas. La méthode consiste à déterminer ensuite si la différence entre la mesure avant le repas déterminée et la mesure après le repas déterminée se situe dans la plage de 50 mg/dL et daviser lutilisateur si la différence est supérieure à environ 50 mg/dL et de lui rappeler de refaire le test après le délai dattente prescrit.
Patent CA-3079496-A1 (CA)
Title: Pharmaceutical composition for enhancing antitumor effect by immune checkpoint inhibitor
Inventor: TANAKA TOHRU
IPC: A61K33/24
Filed: 2018-11-28
Abstract: The object of the invention is to provide a pharmaceutical composition for enhancing the antitumor effect by an immune checkpoint inhibitor. Provided is a pharmaceutical composition for enhancing the antitumor effect by an immune checkpoint inhibitor comprising 5-aminolevulinic acids (ALAs) as the active ingredient.
Patent CA-3080511-A1 (CA)
Inventor: BING NAN
IPC: C12Q1/6881
Filed: 2010-08-20
Abstract: Methods are provided for screening a human subject suffering from cancer to predict risk of hepatotoxicity to lapatinib, or a pharmaceutically acceptable salt or composition thereof, comprising determining whether the human has a HLA genotype selected from the group of: HLA-DQA1*0201, HLA-DQB1*0202, and HLA-DRB1*0701, wherein the presence of such a HLA genotype indicates the human subject is at increased risk of hepatotoxicity compared to the risk expected in a human subject that does not have HLA- DQA1*0201, HLA-DQB1*0202, and HLA-DRB1*0701.
Patent CA-3082156-A1 (CA)
Inventor: LEE HYUK WOO
IPC: A61K31/519
Filed: 2018-10-17
Abstract: La présente invention concerne un nouveau composé ayant une activité d'inhibition de protéine kinase, un stéréoisomère ou un sel pharmaceutiquement acceptable de celui-ci. Le composé, le stéréoisomère ou le sel pharmaceutiquement acceptable de celui-ci selon la présente invention présentent une activité d'inhibition de protéine kinase, ce qui permet de prévenir ou de traiter de manière efficace des maladies associées à la protéine kinase, telles que le cancer, une maladie auto-immune, une maladie neurologique, une maladie métabolique, une infection ou similaires.
Patent CA-3083306-A1 (CA)
Title: Alloy for gas turbine applications with high oxidation resistance
Inventor: HASSELQVIST MAGNUS
IPC: C22C19/05
Filed: 2018-10-24
Abstract: A nickel base super alloy or blade alloy having Ni as a main constituent and the following elements or portions in wt%: Fe: 2 to 8, Al: 6.1 to 6.8, Cr: 12.5 to 15, W: 1.5 to 4.5, Ta: 2.5 to 5.5, Hf: 1.2 to 2, C: 0.03 to 0.13, B: 0.005 to 0.02, Zr: 0.005 to 0.02, and Si: 0.005 to 0.02.
Patent CA-3083728-A1 (CA)
Title: Dimension measurement device
Inventor: SHIRAHARA YOSHINORI
IPC: A61J3/00
Filed: 2018-11-16
Abstract: [Problem] To provide a dimension measurement device capable of accurately measuring medicine dimensions without being influenced by changes in the use environment. [Solution] This dimension measurement device S1 comprises: a light source unit L, a photography unit C, a medicine holding unit H for holding medicine 1 between the photography unit C and light source unit L such that the medicine 1 can be photographed from different directions, a light-source-output adjustment unit U1 for adjusting the luminance of the light source unit L on the basis of the brightness of a photographed image photographed by the photography unit C, and a shape measurement unit U2 for measuring the X dimension and Y dimension of the medicine 1 in mutually orthogonal X direction and Y direction in a photographed image photographed after luminance adjustment has been carried out at least once.
Patent CA-3084710-A1 (CA)
Title: Personal progressive jackpot system
Inventor: SAUNDERS ANDREW MICHAEL
IPC: G07F17/32
Filed: 2018-10-31
Abstract: A personal progressive jackpot system is provided, with the aim of improving player satisfaction. The personal progressive jackpot system comprises, an input member arranged to accept identification information unique to a user, and wager information, the wager information having a wager value. The system further comprises a physical random number generator arranged to generate and output a random number during an operative period;a memory arranged to access and store the identification information, the wager information and the random number, the memory further comprising a personal progressive jackpot value associated with the identification information;a controller arranged to modify the personal progressive jackpot value; and a processor. The processor is arranged to carry out the steps of:link the identification information to a personal progressive jackpot value;calculate a personal progressive jackpot contribution from the wager value; wherein the controller is arranged to increment the personal progressive jackpot value by said personal progressive jackpot contribution;generate a win condition based on the random number; and compare the wager information with the win condition to determine one of:a first outcome, wherein the wagering information satisfies the win condition, and following the first outcome, the controller is arranged to reduce the personalised progressive jackpot value; and a second outcome, wherein the wagering information does not satisfy the win condition; whereby the personal progressive jackpot system provides a personalised gaming experience. In providing a personal progressive jackpot, the present invention allows for a player to contribute solely to their own jackpot total if preferred and reduces the likelihood of player dissatisfaction, which is typically caused by another player winning a jackpot total to which many players contributed.
Patent CA-3086116-A1 (CA)
Inventor: SACCOMAN UMBERTO
IPC: B21B45/02
Filed: 2018-12-19
Abstract: The invention relates to an apparatus (10) for the thermal treatment of metallic products, which comprises (a) a support and transport plane (24) for locating and advancing a product to be treated; (b) at least one collector module (12) comprising (b-1) at least one collector (14, 16), the collector (14) being provided with (b-1.1) a perforated plate (22) on that side of the collector (14) which is facing the support and transport plane (24); (b-2) a conduit (20) connected to said at least one collector (14) for feeding it with a fluid, and (b-3) integrated in said conduit (20), at least one stop valve (18), in particular an on-off valve, to permit or preclude the flow of said fluid into said at least one collector (14). The stop valve (18) is situated at a distance from the collector (14) which does not exceed 60 cm, preferably does not exceed 35 cm, and still more preferably does not exceed 10 cm. The perforated plate (22) is provided with holes (36) which are arranged in rows (38) parallel to each other but not in parallel rows with respect to the sides (22a, 22b) of said perforated plate. The rows (38) are inclined with respect to two opposite sides (22a) of the plate (22) of an acute angle (ß).
Patent CA-3087418-A1 (CA)
Title: Cellules dendritiques heterogenes immatures mortes stimulees par un antigene en tant qu'agents therapeutiques de maladies
Inventor: CAO CHUANHAI
IPC: A61P37/04
Filed: 2019-01-18
Abstract: L'invention concerne des cellules dendritiques immatures sensibilisées par un antigène exogène. La cellule dendritique peut également être morte. Les cellules dendritiques immatures sensibilisées par un antigène exogène peuvent intervenir pour provoquer une réponse immunitaire accrue. L'invention concerne en outre des vaccins comprenant les cellules dendritiques immatures sensibilisées par un antigène exogène, des méthodes d'induction d'une réponse immunitaire chez un patient, et des méthodes de traitement d'une maladie.